Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Clinical Medicine Insights. Oncology|July 12, 2016
Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical PracticeFabien Calcagno, Sabrina Lenoble, Zaher Lakkis, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 25, 2012
Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugsV Nerich, C Borg, C Villanueva, et al.
European Journal of Cell Biology|March 1, 1996
Endogeneously regulated site-specific differentiation of human palmar skin keratinocytes in organotypic cocultures and in nude mouse transplantsA Limat, E Stockhammer, D Breitkreutz, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2017
A systematic review of economic evaluation in pancreatic ductal adenocarcinomaClaire Gérard, Philippe Fagnoni, Angélique Vienot, et al.
Frontiers in Medicine|December 20, 2021
ATMP Environmental Exposure Assessment in European Healthcare Settings: A Systematic Review of the LiteratureMargaux Damerval, Christine Fagnoni-Legat, Aurélien Louvrier, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 28, 2006
Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancerPhilippe Fagnoni, Samuel Limat, Loïc Chaigneau, et al.
The Journal of Biological Chemistry|December 11, 2002
Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditionsIsabelle Viard-Leveugle, Roberto R Bullani, Paolo Meda, et al.
Breast (Edinburgh, Scotland)|November 30, 2011
Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapyN Chaumard, S Limat, C Villanueva, et al.
Anticancer Research|July 31, 2012
First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysisVirginie Nerich, Fernando Bazan, Fanny Compagnat, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 14, 2006
Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancerSamuel Limat, Claire-Hélène Bracco-Nolin, Christine Legat-Fagnoni, et al.
Pageof 15